US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1816 Views
-
Last post by frodo
-
- 0 Replies
- 1163 Views
-
Last post by NHE
-
- 0 Replies
- 1627 Views
-
Last post by frodo
-
- 0 Replies
- 1149 Views
-
Last post by frodo
-
- 1 Replies
- 1578 Views
-
Last post by frodo
-
- 0 Replies
- 1944 Views
-
Last post by NHE
-
- 0 Replies
- 2201 Views
-
Last post by NHE
-
- 0 Replies
- 998 Views
-
Last post by frodo
-
- 1 Replies
- 1312 Views
-
Last post by NHE